The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 6th 2024
The rheumatology month in review emphasizes new trends in medication use and novel technologies' potential for managing fibromyalgia.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Children Face Added Risks With Corticosteroid Use
October 22nd 2020Children who take oral corticosteroids for autoimmune conditions, such as juvenile arthritis, psoriasis, inflammatory bowel disease or other conditions, like asthma, have an increased risk of diabetes, high blood pressure, and blood clots, say researchers writing in the American Journal of Epidemiology.
Total Joint Surgery May Lower Fall Risk
October 22nd 2020A new study published in the Journal of the American Academy of Orthopaedic Surgeons shows that patients with advanced osteoarthritis who undergo total joint replacement, significantly lower their risk of falls after surgery as compared to patients who opt out of surgery.
Quiz: Rheumatic Disease Exercise Dos and Don'ts
October 21st 2020Patients with rheumatic disease are encouraged to participate in regular exercise to reduce the impact of symptoms, such as osteoporosis, and also to protect against the development of other chronic conditions, in particular cardiovascular disease. But which specific symptoms can be improved, and what type of exercise is recommended and how much? Test your knowledge in this quiz.
Doctors Increasingly Skip the Exercise Lecture in Patient Clinic
October 21st 2020Patients with inflammatory arthritis and osteoarthritis should be participating in four different types of exercise: cardiovascular, strength, flexibility, and balance. But a new study shows that patients are overly focused on cardiovascular exercise and not enough on exercise types designed to strengthen and protect joints and bones.
Workforce Shortage in Rheumatology Best Addressed on All Fronts
October 16th 2020In this video, rheumatologist Vaneet Kaur Sandhu, M.D., addresses the workforce shortage in rheumatology. It should be addressed on all fronts, she says. If the workforce shortage doesn't turnaround patients in underserved areas will continue to be treated by physicians, albeit well-intended physicians, with little to no experience in rheumatic disease. Learn more in this interview.
Rheumatoid Arthritis With PTSD, Anxiety and Depression
October 16th 2020Stress and anxiety can wreak havoc on one's health and hinder recovery, particularly for patients with chronic conditions, such as rheumatoid arthritis. In an article published online Sept. 13 in ACR Open Rheumatology, Joshua F. Baker, M.D., and colleagues report the results of study that finds veterans with rheumatoid arthritis and comorbid PTSD, depression, or anxiety, have poor persistence of methotrexate and TNFi therapies leading to worse outcomes. He addresses the study findings in this interview.
Rheumatology News Roundup: Leg Pain
October 16th 2020In this week's news roundup from Rheumatology Network, we focus on surgical treatment for back and leg pain, diagnosing spondyloarthritis, cells that may contribute to rheumatoid arthritis flares, reconsidering a rheumatoid arthritis diagnosis, and more.
Recognizing Axial Spondyloarthritis in Primary Care
October 15th 2020Back pain is the second leading symptom prompting a visit to a primary care physician. Here, we highlight a review of axial spondyloarthritis from Mayo Clinic Proceedings. The review aims to help primary care physicians detect this condition and know when to refer to a rheumatologist.
Surgery May Be Best Option for Sciatica
October 15th 2020A study published in the New England Journal of Medicine earlier this year of patients with sciatica lasting longer than four months due to lumbar disk herniation, finds that microdiskectomy was superior to nonsurgical care in controlling pain six months post-op.
Long-term Quarantine Sanity: A How-to
October 13th 2020A year from now, with all the luck and scientific progress in the world, we’ll be free to roam again. There may be a whole raft of new stressors waiting for us, but the work you do now to help keep your patients mentally healthy will pay off in meaningful ways.
Rheumatoid Arthritis Quiz: Diagnose Early RA
October 13th 2020In order to achieve the best clinical outcomes in rheumatoid arthritis, experts suggest an early diagnosis is essential. Early and prompt treatment is recommended to reduce the risk of permanent joint damage. In this quiz, we test your knowledge about an early rheumatoid arthritis diagnosis.
One-on-one With Dr. Dimitrios Pappas: Etanercept as Monotherapy in RA
October 9th 2020In today’s one-on-one interview, we talk with Dimitrios A. Pappas, M.D., MPH, scientific director of the Corrona RA Registry and an adjunct professor with Columbia University. He and his team recently published results from the registry in ACR Open Rheumatology which show that rheumatoid arthritis patients may be able to maintain remission or low disease activity with etanercept (Enbrel, Amgen) monotherapy long-term treatment.
Rheumatology News Roundup: Crisis in Osteoporosis Care
October 9th 2020In this week's news roundup from Rheumatology Network, we highlight this week's leading stories including two stories on new developments in osteoporosis treatment. In one, a physician-scientist describes "a crisis in the treatment of osteoporosis" due to severe side effects. Learn more about this story and others in this week's news roundup.
Could nitrogen-containing bisphosphonates protect against pneumonia?
October 9th 2020Patients taking nitrogen-containing bisphosphonates have a lower risk of developing and dying from pneumonia after hip fracture compared with patients taking other types of medication for osteoporosis or no drugs for osteoporosis at all, a study published in the Journal of Bone and Mineral Research has found.
Delaying Denosumab Injections Increases Risk of Vertebral Fractures, Study Shows
October 9th 2020Delays to denosumab injections increase the risk of vertebral fractures, a study published in the Annals of Internal Medicine has shown, highlighting the importance of trying to ensure that, while covid-19 is disrupting many medical services, the pandemic does not impact on the timing of denosumab injections.
Individualized Approach Needed for Bisphosphonate Use in Women
October 7th 2020In women 50 years of age or older, the risk of atypical femur fracture increased with longer bisphosphonate use, Asian ancestry, shorter height, higher weight and glucocorticoid use for one year or more, but this risk rapidly decreased after bisphosphonate discontinuation, according to a study recently published in New England Journal of Medicine.
Optimized Treatment Strategies in Axial Spondyloarthritis: an Unmet Need
October 6th 2020Despite major advances in axial spondyloarthritis and an increasing number of therapeutic options, questions remain related to the optimized treatment strategies and to the individual drug choice, according to a review published in Current Rheumatology Reports.
Source of Pain in Fibromyalgia Identified
October 6th 2020Patients with fibromyalgia syndrome may present with elevated intramuscular pressure, which might represent a diagnostic aid in fibromyalgia syndrome and a target for treatment to reduce muscle pressure, according to a study recently published in The Journal of Rheumatology.
COX-2 Inhibitors Best Traditional NSAIDS for Acute Gout
October 5th 2020In patients with acute gout, cyclo-oxygenase-2 (COX-2) inhibitors, especially etoricoxib (Arcoxia, Merck & Co.), may result in a greater clinical response than traditional non-steroidal anti-inflammatory drugs (NSAIDs), according to a study published in BMJ Open.
Genomic Risk Scores May Enhance JIA Diagnosis
October 5th 2020In juvenile idiopathic arthritis, predictive genomic risk scores may enhance current diagnosis protocols, prioritizing higher-risk patients for follow-up and reducing treatment delays, according to a study published this month in Annals of Rheumatic Diseases.
Dapagliflozin Earns Breakthrough Therapy Designation for Chronic Kidney Disease
October 2nd 2020Dapagliflozin (Farxiga, AstraZeneca) has been granted breakthrough therapy designation by the U.S. Food and Drug Administration for patients with chronic kidney disease with and without type 2 diabetes. It is currently approved as a treatment to improve glycemic control in adults with type 2 diabetes.
Secukinumab Not Associated With Tuberculosis
October 2nd 2020Researchers writing in JAMA Dermatology report that latent tuberculosis infection previously assumed to be an adverse event as a result of treatment with secukinumab, is actually uncommon in patients with chronic systemic inflammatory conditions.
Golimumab Approved for Pediatric Forms of Juvenile Arthritis and Psoriatic Arthritis
September 30th 2020Golimumab (Simponi Aria, Janssen/J&J) has been approved by the U.S. Food and Drug Administration for two pediatric conditions:active pediatric juvenile idiopathic arthritis (JIA) and active pediatric psoriatic arthritis.